@BJRimelMD Profile picture

BJ Rimel

@BJRimelMD

Gyn Oncologist, Medical Director of Cancer Clinical trials Office Cedars-Sinai Medical Center, mom, lesbian, opinions that are tweeted are mine, not Cedars

Joined January 2014
Similar User
Stephanie Blank photo

@StephanieVBlank

Joshua Garrett Cohen photo

@JCohenMD

Shannon Westin, MD, MPH, FASCO photo

@ShannonWestin

Shitanshu Uppal photo

@uppals

Ritu Salani photo

@RSalaniMD

David Scott Miller photo

@dsmgyo

Nadeem R. Abu-Rustum photo

@aburustummd

Anil Sood photo

@AnilSoodMD

Rod Rocconi photo

@rodrocconi

Jolyn Taylor photo

@TaylorJolyn

Nicole D. Fleming MD photo

@nicoleflemingmd

Sarah Ackroyd photo

@SarahAckroydMD

Pamela T. Soliman MD photo

@PamSolimanMD

Linus Chuang photo

@gynoncology

rcoledude photo

@rcoledude

Thanks for the shout out! @OBGYN_CS @CSCancerCenter

Our own Dr. BJ Rimel (@BJRimelMD) discusses “Beyond the Rainbow Flag: Topics and Outcomes From the First National LGBTQ+ Cancer Symposium” for @AACI_Cancer Commentary - @CSCancerCenter @ZulSurani @CedarsSinaiMed - aaci-cancer.org/Files/Admin/Co…



Excellent review of bidirectional engagement between Community Advisory Board and researchers at @CSCancerCenter @CedarsSinai @ZulSurani

Tweet Image 1

BJ Rimel Reposted

Tyrosine kinase inhibitor use in gynecologic cancer: appropriate management of unique toxicities is crucial🚨@BJRimelMD @SGO_org @ASCO @SGO_org @IGCSociety @ESGO_society @OncoAlert sciencedirect.com/science/articl…


BJ Rimel Reposted

#ASCO2023. Temporary tattoos ✅

Tweet Image 1

BJ Rimel Reposted

Gabe Sonke: Final survival analysis of phase III OVHIPEC-1 trial ovarian cancer after ten year follow-up. #ASCO23 #gyncsm

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

HIPEC (OVhIPEC1) did not show benefit in BRCAm patients. #ASCO2023 #gyncsm

Tweet Image 1

Heading to #ASCO2023 I love my city. Happy first day of #PRIDE@CSCancerCenter⁩ ⁦@OBGYN_CS

Tweet Image 1

BJ Rimel Reposted

Update on #drugshortages: Teva has a limited supply of the smaller 50mL vials of cisplatin and availability of the 100mL, with recovery to regular supply levels expected in Q4 and Q3, respectively. Call 800-545-8800 for details.

Update on #drugshortages: Accord released addt'l cisplatin supply which should be available to order in coming days. Accord also plans releases soon for carboplatin and methotrexate. @US_FDA is working w/ all companies on increased supply, as well as pursuing importation.



BJ Rimel Reposted

Click here wago.org/annual-meeting… or go to link in bio to submit your abstract for the WAGO 2023 Annual Meeting today! #WAGO

Tweet Image 1

BJ Rimel Reposted

Mortality from #CervicalCancer is a direct reflection of resource distribution. Future research must account for systemic failures to eradicate inequities in addition to the development of novel agents against this disease. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @bjrimelmd @temkins

Tweet Image 1

Visibility matters. Thanks for the shout out. #LGBTQ

B.J. Rimel, MD, says discrimination and fear of #discrimination keep many in the sex and gender minority community from seeking #healthcare. @BJRimelMD #Oncology #LGBTQ healio.com/news/hematolog…



Great shout out for our own Karen Reckamp As the new PCLI steering committee for AACI. #AACI @CSCancerCare

Tweet Image 1

BJ Rimel Reposted

Very much looking forward to welcoming @CFerroneMD 💫 as new Chair of @DeptSurgeryCS @CedarsSinai in January! Dr. Bruce Gewertz @jackgiraffe1 has propelled us to new heights leaving room for only great things ahead..! #SurgOnc #hpbheroines 👩🏻‍⚕️@CSCancerCare

Tweet Image 1

Excited to post about great CME! #obesitymedicine@CedarsSinai

Tweet Image 1

Modeling #WAGO swag at the Annual meeting! ⁦@marla_eliz⁩ ⁦@CSCancerCare

Tweet Image 1

#WAGO just starting now with the opening plenaries. Andrew Li presenting as program chair. @CSCancerCare

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.